PPARGC1A and facioscapulohumeral muscular dystrophy: Together with the mRNA quantification of Pgc1α expression, which showed a substantial reduction in the DIA compared to the TA, the greater severity in the former muscle may provide an explanation for the respiratory dysfunction in FSHD patients [6], although this requires further investigation.